NAMSW
NASDAQ
NewAmsterdam Pharma Company N.V. - Warrant
$21.25
▲ +$1.21
(+6.04%)
Vol 9K
Price Chart
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | $12.8M | $3.0M | $19.1M | $348K | $32K |
| Net Income | — | — | -$92.2M | -$39.5M | -$17.4M | -$72.0M | -$74.9M |
Financial Health
Free Cash Flow
-$41.0M
Net Debt
-$489.8M
Cash
$490.0M
Total Debt
$202K
As of Dec 31, 2025
Top Holders
Top 5: 27.65%Frazier Life Sciences Manag…
10.88%
$10.0M
RA Capital Management, L.P.
7.25%
$6.7M
Affinity Asset Advisors, Llc
5.33%
$4.9M
Bain Capital Life Sciences …
2.17%
$2.0M
Deerfield Management Compan…
2.02%
$1.9M
As of Dec 31, 2025
Latest News
No related news yet